Sanofi CEO Paul Hudson Champions AI in Drug Progress at Davos: “The Agent Isn’t Wedded to the Project for 10 Years” At the Davos World Economic Forum, Sanofi CEO Paul Hudson made a compelling case for the role of artificial intelligence (AI) in revolutionizing pharmaceutical decision-making. Speaking on a panel alongside industry leaders like … Read more
Prescription Drug Prices soar in 2025: A Wave of increases Hits American Patients Table of Contents Prescription Drug Prices soar in 2025: A Wave of increases Hits American Patients Major Players Raise Prices The High Cost of Healthcare in america Prescription Drug Prices Surge in 2025: What’s Behind the Increase? Widespread Increases Across Essential medications … Read more
Pharmaceutical Price Hikes Looming for 2025: Hundreds of Drugs Affected American consumers face another round of rising prescription drug costs. Data analyzed by healthcare research firm 3 Axis Advisors reveals that numerous pharmaceutical giants plan to increase prices on at least 250 brand-name medications starting in January 2025. This includes key drugs like Pfizer’s Paxlovid, … Read more
For the 2024-2025 flu season, the Sanofi Pasteur laboratory plans to distribute its Vaxigrip vaccine. In total, 250,000 doses will be available, divided between the public and private markets. More precisely, the Pasteur Institute and the Ministry of Health should receive 100,000 doses, while the private market, that is to say pharmacies and wholesale distributors, … Read more
RSV, HPV, shingles high value-added vaccine market… Intense competition led by global big pharma (Graphics = Reporter Son Mi-kyung sssmk@) Attention is being paid to whether premium vaccines can be a way for pharmaceutical and bio companies to increase sales. Although there is no government support, companies are competing to secure market share in the … Read more
The public-private partnership contract between the Biological and Reactive laboratories of Mexico (Birmex) and Sanofi It was very harmful to the Mexican State. It is valid for 15 years and will end in 2032. During this period, the company has the exclusivity to sell 15 million influenza vaccines and more than one million hexavalent vaccines … Read more
Sanofi announced on September 2, 2024 that its experimental multiple sclerosis drug tolebrutinib failed to meet the primary endpoint of two late-stage clinical trials. September 2, 2024 • By Handicap.fr with AFP Disappointment. On September 2, 2024, the French pharmaceutical group Sanofi indicated in a press release that the treatment studied did not demonstrate a … Read more
Did the vaccination against Corona save lives or was it disproportionately risky given the side effects that occurred in some cases? Researchers from the UN World Health Organization (WHO) have now presented an estimate based on data. According to this, around 1.6 million lives were saved in Europe by the vaccinations between December 2020 and … Read more
International news 4:33 p.m. 2023-12-15 The White House said Thursday (Dec. 14) that Sanofi and AstraZeneca (AstraZeneca) plans to deliver an additional 230,000 doses of respiratory syncytial virus (RSV) vaccine to infants in January. 2024 after US officials held discussions with both companies about winter vaccine delivery. Sanofi said in a statement: The company will … Read more
2023/11/20 05:30 The new vaccine “Beyfortus” against infant respiratory syncytial virus (RSV) is in short supply. (Associated Press) ◎Chen Chengliang A new shot for infants against RSV is in short supply, and U.S. health officials told doctors they should prioritize giving the drug to babies at the highest risk of severe disease. A new vaccine … Read more